{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:29:19Z","timestamp":1779370159900,"version":"3.53.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","burnsjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.burns.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:53:41Z","timestamp":1528718021000},"page":"1561-1572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications"],"prefix":"10.1016","volume":"44","author":[{"given":"B.","family":"Lipov\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Holoubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hanslianov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cvanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Grossov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zaj\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bukov\u010dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Eimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jandov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ko\u0161\u0165\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brychta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May\u2013June (3)","key":"10.1016\/j.burns.2018.03.006_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clindermatol.2005.02.001","article-title":"Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"issue":"September (3)","key":"10.1016\/j.burns.2018.03.006_bib0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)60789-2","article-title":"Pathogenesis and recent therapeutic trends in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Khalili","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"June (6)","key":"10.1016\/j.burns.2018.03.006_bib0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"April (4)","key":"10.1016\/j.burns.2018.03.006_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"issue":"November\u2013December (6)","key":"10.1016\/j.burns.2018.03.006_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4103\/0378-6323.18007","article-title":"Acute skin failure: concept, causes, consequences and care","volume":"71","author":"Inamadar","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"September (9)","key":"10.1016\/j.burns.2018.03.006_bib0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"issue":"April (8746)","key":"10.1016\/j.burns.2018.03.006_bib0035","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0140-6736(91)90273-R","article-title":"Intestinal involvement in drug-induced toxic epidermal necrolysis","volume":"337","author":"Chosidow","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.burns.2018.03.006_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000234043","article-title":"Toxic epidermal necrolysis with extensive mucosal erosions of the gastrointestinal and respiratory tracts","volume":"80","author":"Roupe","year":"1986","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"February (6)","key":"10.1016\/j.burns.2018.03.006_bib0045","first-page":"87","article-title":"Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System)","volume":"108","author":"Geffers","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.burns.2018.03.006_bib0050","article-title":"Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: epidemiology and general microbiological characteristics","author":"Lipovy","year":"2018","journal-title":"Burns"},{"issue":"August (2)","key":"10.1016\/j.burns.2018.03.006_bib0055","first-page":"149","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"July (1)","key":"10.1016\/j.burns.2018.03.006_bib0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"November\u2013December (6)","key":"10.1016\/j.burns.2018.03.006_bib0065","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/BCR.0b013e3181599bc9","article-title":"American Burn Association consensus conference to define sepsis and infection in burns","volume":"28","author":"Greenhalgh","year":"2007","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2018.03.006_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/2229-5151.134184","article-title":"Catheter-related bloodstream infections","volume":"4","author":"Gahlot","year":"2014","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"November\u2013December (6)","key":"10.1016\/j.burns.2018.03.006_bib0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00004630-199711000-00009","article-title":"Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage","volume":"18","author":"Engelhardt","year":"1997","journal-title":"J Burn Care Rehabil"},{"issue":"March (3)","key":"10.1016\/j.burns.2018.03.006_bib0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1060028014560012","article-title":"Corticosteroids in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: current evidence and implications for future research","volume":"49","author":"Law","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"September (3)","key":"10.1016\/j.burns.2018.03.006_bib0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaad.2013.04.007","article-title":"Methylprednisolone pulse therapy for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers","volume":"69","author":"Hirahara","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"April (4)","key":"10.1016\/j.burns.2018.03.006_bib0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"issue":"August (2)","key":"10.1016\/j.burns.2018.03.006_bib0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","article-title":"Etanercept therapy for toxic epidermal necrolysis","volume":"71","author":"Paradisi","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"December (24)","key":"10.1016\/j.burns.2018.03.006_bib0100","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"issue":"July\u2013August (4)","key":"10.1016\/j.burns.2018.03.006_bib0105","first-page":"413","article-title":"Glucocorticosteroid action on the immune system: molecular and cellular aspects","volume":"9","author":"Boumpas","year":"1991","journal-title":"Clin Exp Rheumatol"},{"issue":"August (3)","key":"10.1016\/j.burns.2018.03.006_bib0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1096-2867(97)80026-6","article-title":"Glucocorticosteroids as immunosuppressive agents","volume":"12","author":"Cohn","year":"1997","journal-title":"Semin Vet Med Surg (Small Anim)"},{"issue":"January (1)","key":"10.1016\/j.burns.2018.03.006_bib0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.132.1.266","article-title":"Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids","volume":"132","author":"Schleimer","year":"1984","journal-title":"J Immunol"},{"issue":"November (5)","key":"10.1016\/j.burns.2018.03.006_bib0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"issue":"November\u2013December (6)","key":"10.1016\/j.burns.2018.03.006_bib0125","first-page":"743","article-title":"High-dose intravenous immunoglobulins in the treatment of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases","volume":"20","author":"Chen","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"July (6)","key":"10.1016\/j.burns.2018.03.006_bib0130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.02082.x","article-title":"Toxic epidermal necrolysis: 15 years\u2019 experience in a Dutch burns centre","volume":"21","author":"Gerdts","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"May (5)","key":"10.1016\/j.burns.2018.03.006_bib0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1468-3083.2011.04143.x","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome at the Prague Burn Centre 1998\u20132008","volume":"26","author":"Zajicek","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"December (8)","key":"10.1016\/j.burns.2018.03.006_bib0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","article-title":"Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre","volume":"35","author":"Rajaratnam","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"February (2)","key":"10.1016\/j.burns.2018.03.006_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002689900361","article-title":"Burn wound infections: current status","volume":"22","author":"Pruitt","year":"1998","journal-title":"World J Surg"},{"issue":"March (2)","key":"10.1016\/j.burns.2018.03.006_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.burns.2005.09.005","article-title":"Meta-analysis of early excision of burns","volume":"32","author":"Ong","year":"2006","journal-title":"Burns"},{"issue":"March\u2013April (2)","key":"10.1016\/j.burns.2018.03.006_bib0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"issue":"January (1)","key":"10.1016\/j.burns.2018.03.006_bib0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","article-title":"Bacteremia in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures","volume":"89","author":"de Prost","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"November\u2013December (6)","key":"10.1016\/j.burns.2018.03.006_bib0165","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/BCR.0000000000000062","article-title":"Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patients","volume":"35","author":"Mahar","year":"2014","journal-title":"J Burn Care Res"},{"issue":"May (5)","key":"10.1016\/j.burns.2018.03.006_bib0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cup.12894","article-title":"Microbiological findings and antibacterial therapy in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis patients from a Swedish Burn Center","volume":"44","author":"Tocco-Tussardi","year":"2017","journal-title":"J Cutan Pathol"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417918301700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417918301700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T11:32:22Z","timestamp":1720351942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417918301700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0305417918301700"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2018.03.006","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}